Safety of Nitroglycerin for Field Treatment of STEMI

CompletedOBSERVATIONAL
Enrollment

940

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
Myocardial Infarction
Trial Locations (3)

90048

Cedars Sinai Medical Center, Los Angeles

90095

UCLA Ronald Reagan Medical Center, Los Angeles

90509

Harbor-UCLA Medical Center, Torrance

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT02407002 - Safety of Nitroglycerin for Field Treatment of STEMI | Biotech Hunter | Biotech Hunter